Influenza A is the most dangerous of the flu types. It causes the majority of severe seasonal flu cases and is the only type responsible for pandemics. In a typical season, flu leads to roughly 180,000 hospitalizations and thousands of deaths in the United States alone, and influenza A drives the bulk of that burden. For most healthy adults, it resolves on its own within a week or two, but for certain groups it can be life-threatening.
Why Influenza A Is More Severe Than Type B
Influenza comes in two main seasonal forms: A and B. Both can make you seriously ill, but influenza A tends to hit harder. In one large clinical comparison, 13.4% of influenza A patients had died within 90 days, compared to 8.7% of those with influenza B. Hospitalization rates were high for both groups (76.5% for A versus 70.8% for B), but type A consistently carried higher risk.
Influenza A also mutates faster. It circulates in animals like birds and pigs, picking up genetic changes that can produce entirely new strains your immune system has never encountered. That’s why every flu pandemic on record, from the 1918 Spanish flu to the 2009 H1N1 outbreak, has been caused by influenza A. Type B circulates only in humans and changes more slowly, which makes it somewhat more predictable from year to year.
How It Damages the Lungs
The flu virus targets the cells lining your airways and the tiny air sacs (alveoli) deep in the lungs. Research in animal models shows that infection becomes survivable only as long as less than about 10% of the key cells lining the air sacs are destroyed. Once damage crosses that threshold, the barrier between your lungs and bloodstream starts to break down.
The virus also disrupts how your lungs clear fluid. It blocks sodium channels and degrades a protein responsible for chloride transport, both of which normally keep fluid from pooling in the air sacs. When these systems fail, fluid accumulates and gas exchange suffers, making it progressively harder to breathe.
On top of that, the virus hijacks a cellular recycling process to help produce more copies of itself. In doing so, it triggers the release of inflammatory signaling molecules that attract waves of immune cells. When that inflammatory response spirals out of control, it becomes what’s often called a cytokine storm: an aggressive immune overreaction that causes further lung damage rather than healing it. A severe cytokine storm can lead to acute respiratory distress syndrome (ARDS), where the lungs fill with fluid, blood clotting goes haywire, and tiny blood vessels in the lungs develop blockages. This is the pathway behind most flu-related deaths in otherwise healthy people.
Complications Beyond the Lungs
Influenza A doesn’t always stay confined to the respiratory system. One of the more alarming complications is heart inflammation (myocarditis), which shows up in roughly 0.4% to 13% of hospitalized flu patients depending on how it’s measured. Autopsy studies suggest the true rate may be much higher: signs of heart muscle damage appear in 30% to 50% of fatal flu cases, even when no cardiac problems were suspected during treatment. Symptoms typically emerge 4 to 7 days after the initial flu symptoms and can include chest pain, fainting, and dangerous heart rhythm disturbances. Among reported cases, mortality is around 23%.
The brain is another target. Influenza-associated encephalopathy is a rapidly progressing condition where consciousness deteriorates within days of infection. It takes several forms, some severe and some milder. The most dangerous version, acute necrotizing encephalopathy, causes multiple brain lesions and can be fatal. A milder form produces a temporary brain lesion that usually resolves with a good outcome. These neurological complications are rare but occur more often in children.
Secondary Bacterial Infections
Flu weakens your airway defenses, creating an opening for bacteria that normally wouldn’t cause serious harm. The three most common culprits are pneumococcus, staph, and a bacterium called Haemophilus influenzae (confusingly named, as it’s a bacterium, not a virus). Pneumococcus is particularly associated with high mortality during flu outbreaks.
These secondary infections typically develop as you seem to be improving from the flu, then worsen again with a new fever, worsening cough, or difficulty breathing. This “getting better then getting worse” pattern is one of the most important warning signs to watch for, in both adults and children.
Who Faces the Highest Risk
Influenza A is most dangerous at the extremes of age. Adults 65 and older account for a disproportionate share of hospitalizations and deaths. Among children, those under 2 face the highest risk, with infants younger than 6 months having the greatest rates of hospitalization and death.
Beyond age, a long list of chronic conditions raises the stakes:
- Lung conditions like asthma, COPD, and cystic fibrosis
- Heart disease, including congenital heart conditions and heart failure
- Diabetes and other endocrine or metabolic disorders
- Kidney or liver disease
- Weakened immune systems from HIV, cancer treatment, or immunosuppressive medications
- Neurological conditions that affect muscle function, breathing, or the ability to clear the airway
- Severe obesity (BMI of 40 or higher)
- Blood disorders like sickle cell disease
Pregnant women remain at increased risk through the first two weeks after delivery. People living in nursing homes and long-term care facilities face elevated danger as well, partly from close quarters and partly from the frailty common in those settings. CDC data also show that Black, Hispanic, and American Indian/Alaska Native populations face higher rates of flu hospitalization.
How Well the Vaccine Protects
Influenza A circulates as two main subtypes: H1N1 and H3N2. Vaccine effectiveness varies by subtype and by season because the virus keeps changing. Early estimates from the current season show the vaccine is about 52% effective against H3N2 across all age groups. Protection against H1N1 has been weaker this season, around 16%, though that estimate carries wide uncertainty.
Those numbers may sound modest, but even partial protection reduces the odds of severe illness, hospitalization, and death. Vaccination is especially valuable for people in the high-risk groups listed above, where the difference between a moderate case and a deadly one can be narrow.
The Treatment Window
Antiviral medications can shorten the duration of illness and reduce the risk of complications, but timing matters enormously. They’re most effective when started within the first 6 to 12 hours of symptoms and lose much of their benefit after 48 hours. For people at high risk of complications, starting treatment as early as possible is critical, even before a test result comes back.
Warning Signs That Need Immediate Attention
Most flu cases, even from influenza A, resolve with rest and fluids. But certain symptoms signal that something more dangerous is developing. In adults, those red flags include difficulty breathing, persistent chest or abdominal pain, confusion or inability to stay alert, seizures, not urinating, and severe weakness. In children, watch for rapid or labored breathing, bluish lips or face, ribs visibly pulling in with each breath, refusal to walk due to muscle pain, no urine for 8 hours, and fever above 104°F that doesn’t respond to fever reducers. Any fever in an infant under 12 weeks warrants immediate care.
The pattern to be most vigilant about: symptoms that improve, then return worse than before. That rebound often signals a secondary bacterial infection or a deepening of lung damage, and it requires prompt medical evaluation.